Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.
about
Increased Uptake of HCV Testing through a Community-Based Educational Intervention in Difficult-to-Reach People Who Inject Drugs: Results from the ANRS-AERLI StudyEighteen- to 30-year-olds more likely to link to hepatitis C virus care: an opportunity to decrease transmissionMedical and Behavioral Approaches to Engage People Who Inject Drugs Into Care for Hepatitis C Virus Infection.Ending hepatitis C in the United States: the role of screening.A longitudinal study of hepatitis C virus testing and infection status notification on behaviour change in people who inject drugsIs increased hepatitis C virus case-finding combined with current or 8-week to 12-week direct-acting antiviral therapy cost-effective in UK prisons? A prevention benefit analysisEditorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye?Correlates of perceived risk of HIV infection among persons who inject drugs in Tijuana, Baja California, Mexico.Sofosbuvir and ribavirin for 6 weeks is not effective among people with recent hepatitis C virus infection: The DARE-C II study.Recommendations for the management of hepatitis C virus infection among people who inject drugs.Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement.Strategies for hepatitis C testing and linkage to care for vulnerable populations: point-of-care and standard HCV testing in a mobile medical clinic.Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico.Access to needle and syringe programs and the relationship to equipment sharing among people who inject drugs in Kermanshah, IranHepatitis C virus prevention and care for drug injectors: the French approachUpdate on global epidemiology of viral hepatitis and preventive strategies
P2860
Q28550235-3383AE7B-30AE-4031-97CA-02BC5AD84948Q33825807-887B7A2A-2370-43D2-BF49-C1FF3DA9E6C5Q33853664-39821B4F-E04C-47AD-B28B-2624F2C12EC6Q33862919-CAFF126D-4567-4116-B8E6-C6A6EE5A3AA7Q35889562-24507561-0155-4D97-84A6-CAC5403390E4Q37035896-2E71E0B3-BD5E-4313-AF07-8BE17122A332Q37604532-64084572-20CA-4E8D-8F32-94648BD016E9Q40328486-DC376E6C-51E5-4DBC-AA2D-D7A4ECD7442CQ40483611-15DC1CFA-B698-47CF-A646-EFF42225C589Q41047662-15FE1AC2-273F-4A5F-A37B-04DA516B53EEQ41546318-375C25AF-99FF-443C-B44D-26BE4349B325Q42199183-036BE1F7-137F-450F-B379-8047F9510D23Q49804072-9598AFDC-D190-48DF-BC61-613D5A1FA7E6Q56890479-D2CF1BB7-1C01-493E-8D15-BB379F99F3A1Q57144432-F826666A-6E60-42AA-A213-63D042B990B9Q59133434-1E7803FA-7C84-472D-A489-A682D9855E21
P2860
Sustained drug use changes after hepatitis C screening and counseling among recently infected persons who inject drugs: a longitudinal study.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Sustained drug use changes aft ...... t drugs: a longitudinal study.
@ast
Sustained drug use changes aft ...... t drugs: a longitudinal study.
@en
type
label
Sustained drug use changes aft ...... t drugs: a longitudinal study.
@ast
Sustained drug use changes aft ...... t drugs: a longitudinal study.
@en
prefLabel
Sustained drug use changes aft ...... t drugs: a longitudinal study.
@ast
Sustained drug use changes aft ...... t drugs: a longitudinal study.
@en
P2093
P2860
P356
P1476
Sustained drug use changes aft ...... ct drugs: a longitudinal study
@en
P2093
Didier Jutras-Aswad
Julie Bruneau
P2860
P304
P356
10.1093/CID/CIT938
P407
P577
2013-12-20T00:00:00Z